Clinical Trial Update: Study to Determine the Effect of Repeated Administration of Diltiazem on the Pharmacokinetics of Darapladib (Sb-480848). [Phase 1]

View source ↗

Summary

Phase 1 study to determine how repeated administration of diltiazem affects the pharmacokinetics of darapladib in individuals with atherosclerosis; the trial ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Drugs mentioned

• Darapladib (darapladib)
• Diltiazem (diltiazem)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Atherosclerosis | Phase 1 | Status: COMPLETED